Near fatal intoxication with controlled-release morphine tablets in a depressed woman

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 5, 1998, Pages 586-589

  Westerling, D ^a   Sawe J ^b   Eklundh, G ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Intoxication; Morphine, controlled release; Plasma and urine morphine concentrations

Indexed keywords

MORPHINE; MORPHINE 3 GLUCURONIDE; NALOXONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; CONTROLLED RELEASE FORMULATION; DEPRESSION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG OVERDOSE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RESPIRATORY FAILURE;

EID: 0031960241     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb05171.x     Document Type: Article

References (22)

1. Hanks G, de Conno F, Ripamonti C, Ventafridda V, Hanna M, McQuay HJ et al. Morphine in cancer pain: modes of administration. BMJ 1996: 312: 823-826.
2. Schug SA, Merry AF, Acland RH. Treatment principles for the use of opioids in pain of nonmalignant origin. Drugs 1991: 42: 228-239.
3. Portenoy RK. Opioid therapy for chronic nonmalignant pain. Pain Res Manage 1996: 1: 17-28.
4. Svensson JO, Rane A, Säwe J, Sjöqvist F. Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography. J Chromatogr 1982: 230: 427-432.
5. Svensson JO. Determination of morphine, morphine-6-glucuronide and normorphine in plasma and urine with high-performance liquid chromatography and electrochemical detection. J Chromatogr 1986: 375: 174-178.
6. Poklis A, Edinboro LE, Wohler AS, Presswalla F, Barren D. Fatal morphine poisoning in a child due to accidental oral ingestion. Forensic Sci Int 1995: 76: 55-59.
7. Hansen A, Pedersen CB. Severe respiratory depression after intake of a sustained-release morphine tablet. Ugeskr Laeger (in Danish) 1994: 156: 4834-4835.
8. Tassinari D, Masi A, Sartori S, Nielsen I, Ravaioli A. Atypical absorption of morphine sulfate through oral mucosa: An unusual case of acute opioid poisoning. J Pain Symptom Manage 1995: 10: 405-407.
9. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A, eds. The pharmacological basis of drug treatment. 9th edn. New York: McGraw-Hill, 1996: 528-533.
10. Koren G, Butt W, Chinyanga H, Soldin S, Tan YK, Pape K. Postoperative morphine infusion in newborn infants: Assessment of disposition characteristics and safety. J Pediatr 1985: 107: 963-967.
11. Sjögren P, Eriksen J. Opioid toxicity. Curr Opin Anaesthesiol 1994: 7: 465-469.
12. Foley KM. Opioid analgesics in clinical pain management. In: Herz A, ed. Opioids II. Handbook of experimental pharmacology, Vol 104. Berlin: Springer-Verlag, 1993: 697-743.
13. Säwe J, Svensson JO, Rane A. Morphine metabolism in cancer patients on increasing oral doses - no evidence for auto-induction or dose-dependence. Br J Clin Pharmacol 1983: 16: 85-93.
14. Säwe J. Morphine and its 3- and 6-glucuronides in plasma and urine during chronic oral administration in cancer patients. In: Foley KM and Inturrisi CE, eds. Advances in pain research and therapy. New York: Raven Press, 1986: 45-55.
15. Osborne R, Joel S, Trew D, Slevin M. Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther 1990: 47: 12-19.
16. Westerling D, Persson C, Höglund P. Plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide after intravenous and oral administration to healthy volunteers: Relationship to nonanalgesic actions. Ther Drug Monitor 1995: 17: 287-301.
17. Kromer W. Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion. Pharmacol Rev 1988: 40: 121-62.
18. Milne RW, Nation RL, Somogyi AA. The disposition of morphine and its 3-and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. Drug Metab Rev 1996: 28: 345-472.
19. Hasselström J, Säwe J. Morphine kinetics and metabolism in man; Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Clin Pharmacokinet 1993: 24: 344-354.
20. Westerling D, Frigren L, Höglund P. Morphine pharmacokinetics and effects on salivation and continuous reaction times in healthy volunteers. Ther Drug Monitor 1993: 15: 364-374.
21. Klaassen CD. Principles of toxicology and treatment of poisoning. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A, eds. The pharmacological basis of drug treatment. 9th edn. New York: McGraw-Hill, 1996: 63-75.
22. Martindale The Extra Pharmacopoeia. Chelating agents, antidotes and antagonists. In: Reynolds JEF, ed. Martindale The Extra Pharmacopoeia, 31st edn. London: Royal Pharmaceutical Society, 1996: 973-974.